NCT04169347 2023-07-27FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal CancerCriterium, Inc.Phase 2 Unknown27 enrolled
NCT01882868 2017-03-14A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in JapanSanofiPhase 2 Completed62 enrolled 34 charts